Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2023 Earnings Convention Name February 21, 2023 4:30 PM ET

Firm Members

Roger Weiss – Lytham Companions

Josh Disbrow – Chief Government Officer

Mark Oki – Chief Monetary Officer

Convention Name Members

Jennifer Kim – Cantor Fitzgerald

Vernon Bernardino – H.C. Wainwright


Greetings. Welcome to the Aytu BioPharma Fiscal 2023 Q2 Outcomes Convention Name. At the moment, all contributors are on a listen-only mode. [Operator Instructions]. Please notice this convention is being recorded.

I’ll now flip the convention over to your host, Roger Weiss. It’s possible you’ll start.

Roger Weiss

Good afternoon, everybody, and thanks for becoming a member of us for Aytu BioPharma’s second quarter fiscal yr 2023 monetary outcomes convention name.

Becoming a member of us right this moment on the decision is Aytu’s CEO, Josh Disbrow; and the corporate’s Chief Monetary Officer, Mark Oki. On the conclusion of right this moment’s ready remarks, we’ll open the decision for a question-and-answer session.

I might wish to remind everybody that right this moment’s name is being recorded. A replay of right this moment’s name can be out there through the use of the phone numbers and convention ID offered within the earnings press launch issued earlier right this moment.

Lastly, I might additionally wish to name to your consideration the customary Secure Harbor disclosure relating to future-looking data. The convention name right this moment will include sure forward-looking statements, together with statements relating to the objectives, methods, beliefs, expectations, and future potential working outcomes of Aytu BioPharma. Though administration believes these statements are cheap primarily based on estimates, assumptions, and projections as of right this moment, these statements will not be ensures of future efficiency. Time-sensitive data could not be correct on the time of any telephonic or webcast replay. Precise outcomes could differ materially on account of dangers, uncertainties, and different components together with, however not restricted to, the components set forth within the firm’s filings with the SEC. Aytu undertakes no obligation to replace or revise any of those forward-looking statements.

Leave a Reply

Your email address will not be published. Required fields are marked *